Urinary tract infection (UTI), the most common of all bacterial infections, affects humans throughout their life span. 20-35% of all women experience at least one episode of UTI sometime in their lives. UTI occurs in all populations, from the neonate to the geriatric patient, but has a particular impact on females of all ages, males at the two extremes of life, kidney transplant patients, and anyone with functional or structural abnormalities of the urinary excretory system. Because of the wide range of individuals affected and because UTI is frequently superimposed on other medical problems, physicians in virtually all specialties are called on to deal with this clinical problem.

COMPOSITION:

Active principle

1 capsule contains: 6 mg of lyophilized bacterial lysates of Escherichia coli.

INDICATIONS/POSSIBILITIES OF USE:

 Immunotherapy Prevention of recurrent lower urinary tract infections. Co-medication in the treatment of acute urinary tract infec¬tions.

Posology and method of administration Preventive treatment and/or consolidation therapy:

1 capsule daily on an empty sto¬mach, for 3 consecutive months.

TREATMENT DURING ACUTE EPISODES:

1 capsule daily on an empty stomach as co-medication to conventional antimicrobial therapy, until disappearance of the symptoms but for at least 10 consecutive days.